How complete is "complete" molecular response in imatinib-treated chronic myeloid leukemia?

Leuk Lymphoma. 2008 Jul;49(7):1230-1. doi: 10.1080/10428190802158461.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Molecular Diagnostic Techniques
  • Neoplasm, Residual / diagnosis*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate